AI assistant
Sending…
Esperion Therapeutics, Inc. — Director's Dealing 2021
May 21, 2021
32771_dirs_2021-05-21_42abb9b1-282e-43d8-a8ac-856790745117.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Esperion Therapeutics, Inc. (ESPR)
CIK: 0001434868
Period of Report: 2021-05-19
Reporting Person: BIOTECH TARGET N V (10% Owner)
Reporting Person: BB BIOTECH AG (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-19 | Common Stock | P | 200000 | $20.3698 | Acquired | 4377964 | Direct |
More from Esperion Therapeutics, Inc.
Merger & Acquisition
2026
Jun 8
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 1
Interim / Quarterly Report
2026
May 8
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Mar 17
M&A Activity
2026
Mar 3